. A large prospective study in childhood ALL has shown that MRD analysis using immunoglobulin (Ig) and T cell receptor (TCR) gene rearrangements as PCR targets can identify good and poor prognosis groups of substantial size that might profit from treatment adaptation. This MRD-based risk group assignment was based on the kinetics of tumor reduction. Consequently, the level of MRD has to be defined precisely in follow-up samples. However, current PCR methods do not allow easy and accurate quantification. We have tested 'real-time' quantitative PCR (RQ-PCR) using the TaqMan technology and compared its sensitivity with two conventional MRD-PCR methods, ie dot-blot and liquid hybridization of PCR amplified Ig/TCR gene rearrangements using clone-specific radioactive probes. In RQ-PCR the generated specific PCR product is measured at each cycle ('real-time') by cleavage of a fluorogenic intrinsic TaqMan probe. The junctional regions of rearranged Ig/TCR genes define the specificity and sensitivity of PCR-based MRD detection in ALL and are generally used to design a patient-specific probe. In the TaqMan technology we have chosen for the same approach with the design of patient-specific TaqMan probes at the position of the junctional regions. We developed primers/probe combinations for RQ-PCR analysis of a total of three IGH, two TCRD, two TCRG and three IGK gene rearrangements in four randomly chosen precursor-B-ALL. In one patient, 12 bone marrow follow-up samples were analyzed for the presence of MRD using an IGK PCR target. The sensitivity of the RQ-PCR technique appeared to be comparable to the dotblot method, but less sensitive than liquid hybridization. Although it still is a relatively expensive method, RQ-PCR allows sensitive, reproducible and quantitative MRD detection with a high throughput of samples providing possibilities for semi-automation. We consider this novel technique as an important step forward towards routinely performed diagnostic MRD studies.
Introduction
Thanks to advances in modern chemotherapeutic regimens over the last decades complete clinical remission can be induced in virtually all children and 75-80% of adults diagnosed with acute lymphoblastic leukemia (ALL). [1] [2] [3] However, one-third of childhood ALL and more than half of adult ALL patients are suffering from disease recurrence and further treatment intensification leads to increased treatment-related toxicity and secondary malignancies. In order to increase the survival along with an improvement of long-term quality of life, individualization of the treatment may be needed. This can be realized via minimal residual disease (MRD) studies that allow the detection of leukemic cells invisible by normal cytomorphologic examination, thereby providing accurate information about the efficacy of cytostatic treatment. [4] [5] [6] MRD analysis can predict outcome by determining the reduction of the leukemic cell burden during the first months of therapy. [7] [8] [9] [10] [11] A method that allows sensitive MRD detection in the majority of ALL patients is PCR analysis of clonogenic rearrangements of immunoglobulin (Ig) and T cell receptor (TCR) genes. [10] [11] [12] [13] Junctional regions of Ig and TCR gene rearrangements can be regarded as leukemia-specific DNA fingerprints, owing to the deletion and random insertion of nucleotides during the recombination of the various V, D and J gene segments. 14, 15 Using PCR analysis of these junctional regions, it is possible to detect one leukemic cell in a background of approximately 10 4 to 10 6 normal cells. This is about 100 to 100 000 times more sensitive than obtained with cytomorphology. 5, 6 Yet, oligoclonality of Ig/TCR gene rearrangements may occur in the presence of an active recombination machinery, since these rearrangements are not linked to the oncogenic process. [16] [17] [18] [19] Furthermore, continuing rearrangements and secondary rearrangements during the disease course might result in the loss of the junctional regions initially identified at diagnosis. [20] [21] [22] It therefore seems important to monitor ALL patients with two or more independent monoclonal Ig/TCR PCR targets to prevent false-negative results during follow-up. 6, 11 A patient-specific PCR primer or probe is usually designed to the sequence of the junctional region in order to detect the leukemia within the background of normal cells that may have similar gene rearrangements but different junctional regions. In particular, the usage of a patient-specific junctional region probe has shown to be highly effective in the detection of MRD.
11, 23 After PCR amplification of the Ig/TCR gene rearrangement, the PCR product is hybridized with the radio-actively labeled patient-specific probe. For that purpose, the PCR product is blotted after gel electrophoresis or directly spotted on a nitrocellulose membrane, the so-called dot-blot method. 6, 23 Alternatively, the PCR product is not fixed to a filter but hybridized as free DNA in liquid hybridization. 24 Although these MRD-PCR techniques are highly sensitive, they provide merely semi-quantitative data owing to post-PCR 'end-point' analysis. The PCR technique has the ability to amplify target DNA up to a plateau. Consequently it is impossible to define precisely the initial amount of target DNA. Strategies to overcome the limited quantitative potential of the PCR are the performance of competitive PCR or limiting dilution. 25 Quantitation by competitive PCR is performed by comparing the PCR signal of the specific target DNA with that of known concentrations of an internal standard, the competitor. 25, 26 Quantitative estimations with the limiting dilution assay are established by using serial dilutions in multiple replicates of the target DNA. The dilution end-point defines the amount of initial target DNA via Poisson's law.
27,28 Both approaches are laborious, require multiple PCR analyses per sample and are therefore difficult to perform routinely.
Several large prospective clinical MRD studies in childhood ALL have shown that it is important to determine precisely the level of MRD for discrimination between low and high risk patients. [9] [10] [11] This was found especially when early remission time-points were analyzed; at later time-points low MRD levels are also associated with a high risk of disease recurrence.
11
By using the kinetics of tumor reduction during the first 3 months of therapy it was possible to recognize a low risk group (ෂ43% of patients) with a 3-year relapse rate of only 2%, an intermediate risk group (ෂ43%) with a 3-year relapse rate of ෂ25%, and a high risk group (ෂ15%) with a 3-year relapse rate of 75%. 11 In the light of these results we were aiming at a fast method that can generate reliable quantitative MRD data to provide the means for stratification of ALL patients in the near future.
Recently, a novel technology has become available, the 'real-time' quantitative PCR (RQ-PCR). 29 This assay exploits the 5Ј-3Ј nuclease activity of the Taq polymerase to detect and quantify specific PCR products as the reaction proceeds. 30 Upon amplification, an internal fluorogenic TaqMan probe specific for the target sequence is degraded resulting in emission of a fluorescent signal that accumulates during the reaction. Because of the real-time detection, the method has a very large dynamic detection range over five orders of magnitude, thereby eliminating the need for performing serial dilutions of follow-up samples. Quantitative data can be accomplished in a short period of time, since post-PCR processing is not necessary. Several groups have shown that RQ-PCR via the TaqMan technology can be used for the quantitative detection of MRD using leukemia-specific chromosome aberrations as PCR targets, ie t(9;22), t(14;18) and t(8;21). [31] [32] [33] This is the first report on the usage of RQ-PCR for sensitive and quantitative detection of MRD using Ig and TCR gene rearrangements as PCR targets. For this purpose we designed TaqMan probes at the position of the junctional region of 10 different Ig and TCR gene rearrangements to detect and quantify leukemia-specific PCR products. The sensitivity of RQ-PCR analysis was compared with that of conventional MRD-PCR techniques, like dot-blot and liquid hybridization of PCR amplified Ig/TCR gene rearrangements. In addition, bone marrow (BM) follow-up samples of a precursor-B ALL patient were analyzed for MRD by RQ-PCR. These experiments revealed that junctional regions can be used for TaqMan probe positioning and that RQ-PCR analysis provides sensitive and quantitative MRD information. 
Materials and methods

Patients and cell samples
Patient-specific probes
Sequences of the junctional regions were obtained by direct sequence analysis of the Ig/TCR gene rearrangements with the Dye Terminator Ready Reaction Cycle Sequencing Kit on an ABI PRISM 377 Automated Sequencer (PE Biosystems, Foster City, CT, USA). The template DNA used in the sequence reaction was either the PCR product or a homo-(or hetero-) duplex band excised and eluted from a polyacrylamide gel. 18, 39, 40 Based on the sequence data obtained, patient-specific oligonucleotides were developed complementary to the sequence of the junctional region ( Table 1 ). Oligonucleotides that were likely to form secondary structures were avoided.
Fluorochrome labeled TaqMan probes were designed with the Primer Express software (PE Biosystems). According to the manufacturer's guidelines, the TaqMan probe did not start with a G, contained more C's than G's, and the melting temperature (Tm) was around 68°C, which was 8-9°C above the Tm of the matching primers to ensure proper hybridization to the target sequence. FAM was chosen as reporter dye at the 5Ј end of the TaqMan probe and TAMRA as the quencher dye at the 3Ј end.
OLIGO 5.1 software (Dr W Rychlik, National Biosciences, Plymouth, MN, USA) was applied to design oligonucleotide probes for radioactive end-labeling with ␣-32 P-dATP according to standard protocols. 38 The Tm's of the radioactive probes ranged between 65 and 68°C.
RQ-PCR analysis
Primers matching to the designed TaqMan probes (Table 1) were developed using Primer-Express software (PE Biosystems) and had Tm's of 58-60°C. IGH-1 primers: forward, 5Ј-CACGGCTGTGTATTACTGTGCAA-3Ј and reverse, 5Ј-GGTCGAACCAGTACCCAATAGC-3Ј. IGH-2 primers: forward, 5Ј-GAGGACACGGCTGTGTATTACTGT-3Ј and reverse, 5Ј-ACCTGAAGAGACGGTGACCAT-3Ј. IGH-3 primers: forward, 5Ј-GAGGACACGGCTGTGTATTACTGT-3Ј and reverse, 5Ј-AGACGGTGACCAGGGTTCC-3Ј. Forward primer for 
The most recent nomenclature was used to designate IGH gene segments. 45,46 b Underlined sequences represent randomly inserted nucleotides of the junctional region. IGK-1, 5Ј-AGCAGGGTGGAGGCTGA-3Ј and for IGK-2 5Ј-GGTCAGGCACTGATTTCACACT-3Ј, and reverse primers for both IGK-1 and IGK-2 5Ј-AAAAATGCAGCTGCAGACTCA-3Ј. TCRG primers (TCRG-1 and -2): forward, 5Ј-GCATGAGGAG-GAGCTGGA-3Ј and reverse, 5Ј-GGAAATGTTGTATTCTT-CCGATACTTAC-3Ј. TCRD-1 primers: forward, 5Ј-GTACTTAAGATACTTGCACCATCAGAGA-3Ј and reverse, 5Ј-GAAGCTGCTTGCTGTGTTTGTC-3Ј. TCRD-2 primers: forward, 5Ј-GCAAAGAACCTGGCTGTACTTAAG-3Ј and reverse, 5Ј-GTTTTTGTACAGGTCTCTGTAGGTTTTGTA-3Ј. The forward and reverse primers to detect and quantify MRD via the IGK-3 target in follow-up samples of patient 5257 were: 5Ј-TGTCAGCAGTATGGTAGCTCACC-3Ј and 5Ј-AGTGGATATGGCAAAAATGCA-3Ј, respectively.
For RQ-PCR analysis the TaqMan PCR core reagent kit was used (PE Biosystems). Reaction mixtures of 50 l contained the TaqMan buffer A with the ROX dye as the passive reference, 5 mM MgCl 2 , dNTP's (0.3 mM dATP, 0.3 mM dCTP, 0.3 mM dGTP), and 0.6 mM dUTP), 50-900 mM primers, 1.25 U AmpliTaq Gold (PE Biosystems), 1 U uracil-N-glucosidase (UNG) and 50-1000 ng of DNA. The two-step amplification protocol consisted of a 2-min incubation step at 50°C (digestion of PCR product contaminants by UNG), 10 min at 95°C (inactivation of UNG, denaturation of target DNA, and activation of AmpliTaq Gold), followed by target amplification via 40-70 cycles of 15 s at 95°C and 1 min at 60°C.
Real-time information was obtained using the ABI PRISM 7700 Sequence Detection System containing a 96-well thermal cycler (PE Biosystems). During the PCR, the TaqMan probe first hybridizes to the DNA target, followed by primer annealing. With the TaqMan probe still intact, the emission of the reporter dye is quenched, but during the extension phase of the reaction the TaqMan probe is cleaved by the nuclease activity of the Taq polymerase. This cleavage generates fluorescent reporter signal, which is proportional to PCR product accumulation. The fluorescence intensity is normalized using the passive reference ROX present in the buffer solution. Normalization corrects for fluorescence fluctuations which are PCR-independent. A real-time amplification plot is generated using the normalized reporter signal (Rn). The PCR product yield or ⌬Rn is defined as the Rn minus the baseline signal established in the first few cycles of the PCR. The cycle threshold (C T ) is the PCR cycle at which a statistically significant increase in ⌬Rn is first detected (at least 10 times the standard deviation of the noise). A standard curve is established using the C T s of a serial dilution of target DNA.
To correct for the quantity and quality (amplifiability) of DNA in follow-up samples, we used the gene encoding albumin. Sequences for TaqMan probe, forward primer, and reverse primer, to amplify and detect the albumin gene were kindly provided by Dr EJBM Mensink (Nijmegen, The Netherlands): 5Ј-TGCTGAAACATTCACCTTCCATGCAGA-3Ј, 5Ј-TGAAACATACGTTCCCAAAGAGTTT-3Ј, and 5Ј-CTCTCC-TTCTCAGAAAGTGTGCATAT-3Ј, respectively. An albumin standard curve was established using MNC DNA diluted in water. Corrections on MRD quantities in follow-up samples were performed according to the manufacturer's guidelines (PE Biosytems). Briefly, the quantities established by the leukemia-specific target were divided by that of albumin. Subsequently, the diagnosis quantity was set at 1.0 and leukemia-specific quantities in follow-up samples were related to that at diagnosis resulting in an accurate tumor load determination. Standard deviations were corrected accordingly.
All RQ-PCR experiments were performed at least in triplicate. Before determining the sensitivity of the PCR target, the RQ-PCR was optimized. Since the primer concentration affects the Tm, it can be used to optimize amplification efficiency on a fixed annealing temperature. Therefore, the amount of forward and reverse primer was determined that resulted in the highest ⌬Rn and lowest C T . In the primer-matrix experiment, nine combinations of 50, 300 and 900 mM for each primer were tested in triplicate, ie 50/50, 50/300, 50/900, 300/50, 300/300, 300/900, 900/50, 900/300 and 900/900.
Conventional MRD detection techniques PCR amplification:
The primers used for the PCR analysis of the Ig/TCR gene rearrangements were described previously. 12, 36, 40, 41 For the amplification of IGK, TCRD and TCRG gene rearrangements, 100 l reaction mixtures contained 1 g DNA, 30 pmol of each primer, 1 unit AmpliTaq Gold (PE Biosystems), 1.5 mM MgCl 2 , 200 M dNTP (Pharmacia, Uppsala, Sweden). The cycling protocol consisted of 3 min of initial denaturation at 92°C, followed by 40 cycles of 45 s at 92°C, 90 s at 60°C, 2 min at 72°C, and a final extension phase of 10 min at 72°C. 41 Rearrangements of the IGH gene locus were amplified in 50 l reactions containing, 1 g DNA, 30 pmol of each primer, 2 units Taq polymerase, 2 mM MgCl 2 , and 200 M dNTP. The cycling protocol consisted of 7 min of initial denaturation at 95°C, followed by 30 cycles of 30 s at 95°C and 45 s at 55°C, and a final extension phase of 7 min at 72°C. 12 PCR products were examined after gel electrophoresis in ethidium bromide stained 1% agarose or 10% polyacrylamide gels.
Dot-blot hybridization:
After PCR amplification of the Ig/TCR gene rearrangements, 5 l of the denatured PCR product was spotted in duplicate on to a Nytran N13 nylon membrane of 0.45 m (Schleicher & Schuell, Dassel, Germany) and cross-linked by UV exposure. The filter was hybridized at 50°C for 2 h with 0.5-1.0 pmol of the radioactively labeled patientspecific probe per ml hybridization buffer. 38, 41 Filters were subsequently washed for 20 min in 3 × SSC, 0.1% SDS at 50°C. Radioactive signals were evaluated by phosphor imaging (STORM-820; Molecular Dynamics, Sunnyvale, CA, USA).
Liquid hybridization:
Five microliters of PCR product was hybridized with approximately 1 ng of the radioactively labeled probe in 2 × SSC buffer for 15 min at 60°C after denaturation for 10 min at 95°C. Subsequently, the mixtures were size separated by electrophoresis through a 10% polyacrylamide gel. Radioactive signals were evaluated by autoradiography after drying of the gels. 24 
PCR target sensitivity
To determine the sensitivity of the PCR target, DNA from the sample at diagnosis was diluted in 10-fold steps into DNA from normal mononuclear cells (MNC), down to 10
. To avoid skewed gene rearrangement patterns and to obtain a bulk of the polyclonal control, the normal MNC DNA was derived from equivalent mixtures of 10 different healthy donors. The dilution series was subjected to (RQ)PCR analysis together with appropriate positive and negative controls. The last dilution of diagnosis DNA that gave a radioactive or fluorescent signal, in the absence of a signal from the polyclonal control DNA was defined as the sensitivity threshold of the PCR target. The sensitivity threshold, based on theoretical calculations, could be maximally 10 −4 (approximately eight copies of the target gene) or 10 −5 (approximately 0.8 copies of the target gene).
Results
RQ-PCR analysis
Ten Ig/TCR gene targets (three IGH, two TCRD, two TCRG, and three IGK) of four precursor B-ALL were examined for their sensitivity. For all gene rearrangements, it was possible to develop primers/probe combinations that resulted in successful amplification and real-time detection upon RQ-PCR analysis. In primer-matrix experiments different ⌬Rn values were found for the different primer combinations, while the C T values were comparable. The 300/300 nM primer combinations were used in all sensitivity experiments performed, although other combinations sometimes had equal ⌬Rn values. For six out of 10 PCR targets the TaqMan probe was designed complementary to the reverse strand of the junctional region, due to the high extent of Gs (Table 1 ). The initial primer pair to amplify the two TCRG PCR targets resulted in low sensitivities (10
), which was unexpected because both gene rearrangements involved the rarely used V␥7 gene segment. A new primer pair was designed, given in the Materials and methods section, which was used in combination with the initially designed TaqMan probes; subsequent RQ-PCR analysis resulted in better amplification with higher sensitivities for both TCRG targets ( Table 2 ). All other primers/probe combinations initially designed using Primer Express resulted in efficient amplification according to the amplification plots and sensitivities obtained.
In three out of the four patients (2145, 5160 and 5257) sensitivities of 10 −4 and 10 −5 were obtained, whereas in patient 5199 the sensitivities of most targets (five out of seven) was 10 −3 . This tendency to lower sensitivities in patient 5199 was at least partly related to subclone formation (see Discussion).
Standard curves were established from the results of the dilution experiments and displayed for all 10 PCR targets a linear correlation between the C T and the 10-fold dilution logarithm of the initial DNA target concentration (Figure 1 ). The dynamic range spanned over up to five orders of magnitude. Triple or quadruple experiments had similar values, but at lower target concentrations some variation in the C T was observed (Figure 1) .
Comparison of sensitivities of the three detection methods
Dot-blot and liquid hybridization used the same PCR products and radioactive probes, but different hybridization methods. The sensitivity results obtained with these conventional methods were compared with those of the RQ-PCR analyses, which used specially designed primers/probe combinations, but the same DNA dilutions (Figure 2) . The RQ-PCR analyses were performed in triplicate, testing a total of 1.5 g (500 ng per test), whereas the dot-blot and liquid hybridization methods used 1.0 g.
The sensitivities of RQ-PCR analysis were comparable to those of the dot-blot method (Table 2 ). Using the IGK-2 PCR target in one out of three experiments even a higher sensitivity was found with RQ-PCR compared to dot-blot analysis ( Figure  2 ), but for most other PCR targets similar or 10-fold lower sensitivities were obtained. In contrast, liquid hybridization was always more sensitive, either 10-fold or even 100-fold ( Table 2) .
The lowest sensitivity (10 −2 to 10 −3 ) was obtained with the TCRD-2 target of patient 5199 containing a junctional region without insertion (Table 1) . For this reason, the specificity of the patient-specific probes was limited. To decrease background signals, the liquid hybridization temperature was increased to 64°C and an extra washing step (1 × SSC, 0.1% SDS at 55°C) was necessary to remove background signal from the dot-blot. To increase the stringency in RQ-PCR analysis, we performed another experiment in which the annealing/extension temperature was increased to 63°C and the amount of TaqMan probe lowered to 100 nM. However, this still resulted in a ⌬Rn for the polyclonal MNC control, thereby limiting the sensitivity to 10 −2 .
MRD analysis of follow-up samples using RQ-PCR
A total of 12 BM follow-up samples from patient 5257, taken during and after treatment, were available for MRD analysis. RQ-PCR analyses using IGK-3 (VkIII-Kde gene rearrangement) were performed in triplicate, and diagnosis dilutions and follow-up samples were analyzed in parallel. In addition, diagnosis and follow-up samples were checked for the amount and amplifiability of the DNA by parallel RQ-PCR analysis of the albumin gene. MRD quantities of follow-up samples were first normalized to the albumin quantities and the MRD levels were subsequently determined in relation to the diagnosis sample, resulting in a relative tumor load (Table 3) . With a sensitivity of approximately 10 −5 (only one out of three experiments reached a 10
), the first four time-points appeared to be MRD-positive; the level of MRD slowly decreased from 1.3 × 10 −2 at week 5 down to 2.2 × 10 −4 at week 33 (Table 3 ). All further follow-up samples were MRDnegative including at the end of treatment (week 158) until relapse that emerged almost 4 years after diagnosis (Table 3) . 
Discussion
The aim of this study was to test the value of RQ-PCR analysis using the TaqMan technology for sensitive and quantitative detection of MRD in follow-up samples using rearranged Ig and TCR genes as PCR targets and junctional region-specific TaqMan probes. This technique was applicable for all 10 PCR targets tested in the four patients, ie complete IGH (n = 3), IGK-Kde (n = 3), TCRG (n = 2), and incomplete TCRD (n = 2) gene rearrangements. The majority of PCR targets tested (seven out of 10) were derived from patient 5199. The reason for analyzing most (seven out of eight) of the Ig/TCR gene rearrangements of this patient was to prevent selection of 'sensitive' targets and to obtain insight into the possibilities for Experiments were performed in triplicate. b RQ-PCR analysis of the albumin gene was performed for diagnosis and all follow-up samples in triplicate. The amount of amplifiable DNA that was used in the PCR appeared at week 5: 75% ± 4%, week 13: 61% ± 8%, week 23: 68% ± 5%, week 33: 29% ± 5%, week 191: 55% ± 2% of the amount of DNA that was put into the PCRs of the undiluted sample at diagnosis.The mean MRD levels of the follow-up samples were normalized to the diagnosis sample. c Average quantity calculated based on the three tests, although in one of the three reactions no leukemia target was found.
finding suitable primers and TaqMan probe combinations for RQ-PCR analysis. All junctional region-specific TaqMan probes developed were able to detect leukemia-derived DNA and did not interfere with the PCR efficiency.
The high number of PCR targets in patient 5199 was at least partly related to oligoclonality at diagnosis. This was evident from Southern blot analysis of the IGH, TCRG and TCRD gene rearrangements. Two other findings also pointed towards oligoclonality in this patient: (1) a large proportion of the Ig/TCR rearrangements appeared not to be stable at relapse (data not shown); 21 and (2) , while in a series of over 400 dot-blot dilution analyses approximately 90% of the PCR targets reached a sensitivity of at least 10 −4 . 41 Therefore, the PCR targets of patient 5199 are only informative for comparison of the three techniques, but not for determining the sensitivity of the RQ-PCR technique. In contrast to the oligoclonal patient 5199, all three techniques reached maximal sensitivities of 10 −4 and 10 −5 when examining the IGH, IGK, and TCRD targets in patients 2145, 5160 and 5257.
The combined results show that the sensitivities obtained with the RQ-PCR technique were similar or somewhat lower than those obtained with the dot-blot method. The liquid hybridization with radioactively labeled probes appeared to be more sensitive. In principle, it should be possible to reach higher sensitivities with RQ-PCR, since hybridization with the TaqMan probe is also a form of liquid hybridization, unless the total detection system based on fluorescence is less sensitive than radiography. However, Luthra et al 32 found that RQ-PCR was more sensitive for detecting of t(14;18) than the conventional PCR analysis followed by hybridization of the blotted PCR product with radioactively labeled probes.
In another RQ-PCR application, one point mutation appeared to be sufficient for allelic discrimination by the TaqMan probe. 42 The Tm of the TaqMan probe was in this case 5 to 6°C (instead of 8 to 9°C) above that of the corresponding primers. This adaptation may also be necessary to increase the specificity and sensitivity of RQ-PCR analysis of the TCRD-2 target in this study, which lacked randomly inserted nucleotides. This would mean that for this target a new TaqMan probe should be developed.
An alternative approach in RQ-PCR analysis of Ig/TCR gene rearrangements might be to use a TaqMan probe positioned at germline sequences (V, D or J gene segments) in combination with one or two patient-specific junctional region primers. A similar strategy has also been used for conventional MRD detection using Ig/TCR gene rearrangements as PCR targets. 23, 43, 44 Such a TaqMan probe design is more cost-effective, since it would not be necessary to design probes per patient but per type of rearrangement. However, standardization will be more difficult, since adaptation of PCR protocols and primer design will be needed per case to obtain optimal amplification as well as efficient nuclease activity for cleavage of the TaqMan probe. Nevertheless, comparative studies should demonstrate which strategy gives best sensitivity, although this also may vary per target type.
Twelve BM follow-up samples of precursor-B-ALL 5257 were analyzed for MRD by RQ-PCR, using a VkIII-Kde gene rearrangement. The standard curve, established with the diagnosis dilution series, was used to define the initial amount of leukemic DNA in follow-up samples based on their C T . Subsequently, the MRD level was corrected relative to the diagnosis sample based on parallel RQ-PCR analyses of the albumin gene. A slow decrease of tumor load was observed during the first year of treatment. According to our clinical MRD study, this is indicative of a poor outcome, ie the leukemia is relatively resistant to the given treatment. 11 Indeed, this patient relapsed almost 2 years after cessation of therapy and more than 7 months after the last time-point analyzed, which was still MRD-negative.
Our data show that real-time PCR analysis allows accurate definition of the level of MRD in bone marrow follow-up samples, which is a major improvement to the end-point PCR results of conventional MRD-PCR methods. This is illustrated by the low standard deviations obtained in the triplicate experiments of patient 5257 (Table 3) . A previous study on the applicability of this technique for MRD detection using the BCR-ABL fusion transcripts, also showed a small variation in C T of only 15% in 10 consecutive RQ-PCR analyses. 31 The RQ-PCR technique takes advantage of the first productive PCR cycles for quantitation, where PCR fidelity is still high, exhaustion of reagents does not yet exist, and potential inhibitory effects are minimal. Due to the semi-automated system it is feasible to analyze more DNA per follow-up sample. This does not only result in a more accurate definition of the tumor load in the follow-up sample, but simultaneously increases the sensitivity of the MRD detection. The sensitivity ultimately depends on the maximal number of cells tested: by performing the experiment in quadruplicate, 2 to 4 g of DNA may be analyzed, corresponding to approximately 5 × 10 5 cells. The results presented here demonstrate that RQ-PCR using the TaqMan technology is applicable for MRD analysis via detection of clone-specific Ig/TCR gene rearrangements. RQ-PCR offers many advantages over currently used techniques. The dot-blot and liquid hybridization are dependent on using radioactive isotopes and require individual optimization of the hybridization or washing steps. In contrast to these methods RQ-PCR analysis is simple and fast. The data can be acquired as soon as the PCR is completed without any post-PCR handling, ie within 3 h, instead of 4 to 5 days generally required for conventional methods. Furthermore, the closed system minimizes the risk of PCR product contamination, which is highly relevant in studies where minimal amounts of target DNA are amplified. Most importantly, this novel technique allows accurate quantification of MRD, essential for discrimination between patients with good and poor prognosis. 11 Therefore, we consider this sensitive and reproducible RQ-PCR technique as an important step forward in the clinical application of MRD studies.
